Search Results - "Chhaya, Gaurav"

Real-World Assessment of Personalized Approach With Voglibose Fixed-Dose Combination in Type 2 Diabetes Mellitus by Parmar, Nirmal, Gupta, Ajay Kumar, Jhaveri, Kunal, A, Balachandran, Chhaya, Gaurav, Kansara, Sandeep, Nair, Rathish, Korukonda, Krishnaprasad R

“…Post-prandial hyperglycemia (PPHG) remains a complex aspect in the management of type 2 diabetes mellitus (T2DM) in the Indian population due to uncertainty in…”
Get full text

A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG) by Kansagra, Kevinkumar, Parmar, Deven, Mendiratta, Sanjeev Kumar, Patel, Jatin, Joshi, Shuchi, Sharma, Nitin, Parihar, Anurag, Bhoge, Swapnil, Patel, Harilal, Kalita, Pankaj, Munshi, Renuka, Kurmi, Prakash, Shah, Ruchir, Gupta, Abhishek, Bhalla, HiraLal, Bekkalele, Harish, Verma, RajendraKumar, Agarwal, Dinesh, Sharma, Shrikant, Gawande, Avinash, Chhaya, Gaurav

“…Abstract Background Limited supply, cost and potential for severe adverse effects observed with the blood derived rabies immunoglobulin products has led to…”
Get full text

Reply to Agrawal and Kumar by Kansagra, Kevinkumar, Parmar, Deven, Mendiratta, Sanjeev Kumar, Patel, Jatin, Joshi, Shuchi, Sharma, Nitin, Parihar, Anurag, Bhoge, Swapnil, Patel, Harilal, Kalita, Pankaj, Munshi, Renuka, Kurmi, Prakash, Shah, Ruchir, Gupta, Abhishek, Bhalla, Hira Lal, Bekkalele, Harish, Verma, Rajendra Kumar, Agarwal, Dinesh, Sharma, Shrikant, Gawande, Avinash, Chhaya, Gaurav

Get full text

1113-P: Six Months Comparative Evaluation of Efficacy and Safety of Wockhardt’s Biosimilar Insulin Glargine (Glaritus®) with Reference Insulin Glargine (Lantus®) in Type 2 Diabetes Mellitus in India by SHARMA, SURENDRA, AJMANI, AJAY KUMAR, KHOSLA, POOJA, MUKHOPADHAYAY, PRADIP, BHATIA, GIRISH, KG, PRAKASH, CHHAYA, GAURAV, SUPE, PRAVIN, PAVITHRAN, VINODKUMAR, BORA, HRISHIKESH, SHAH, AGAM, INGOLE, SHAHU ASHOK, JAIN, RISHI

“…Introduction: Glaritus® has been found comparable to reference insulin glargine in physico-chemical characteristics, pre-clinical studies and treatment of type…”
Get full text